Understanding Basic Stock Data: Bioverativ Inc. (BIVV)

In the past 52-week period, shares of Bioverativ Inc. (NASDAQ:BIVV) have moved within the range of $40.00 to $64.41. On the stock’s most recent trading day, the company’s shares ended the regular session at $62.71, which is 2.64% lower than its 52-week high.

Bioverativ Inc. (BIVV) has demonstrated a 20-day simple moving average (SMA) of 14.63%, and a 50-day SMA of 17.54%. This public company’s current market capitalization stands at $6.82 billion.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Checking the amount of enthusiasm that Wall Street analysts hold for a particular stock is crucial when thinking about entering a position. According to the latest data, the consensus recommendation for Bioverativ Inc. (BIVV) is Outperform.

Public companies normally post earnings and revenue results that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Bioverativ Inc. (BIVV) delivered a 2.14% surprise with its net revenue. Sales reached $0.29 billion during the three-month period, compared to the average analyst estimate of $0.29 billion.

Meanwhile, during the same quarter Bioverativ Inc. (BIVV) delivered a 16.48% earnings surprise. Net earnings for the quarter were posted at $0.80 per share, whereas Wall Street had forecast $0.69 per share.

Ownership at Bioverativ Inc. (BIVV), According to Most Recent SEC Filings

A publicly-traded organization’s latest 13F filings tell us important details about its institutional ownership. Bioverativ Inc. (BIVV) has 0 billion shares outstanding currently, 96.55% of which belong to institutional investors. Those institutional holdings amount to $6.14 billion.

Additionally, according to the most recent 13F filing from Bioverativ Inc. (BIVV), there were 52 new positions totaling 3,437,392 shares of the company’s stock. There were 54 sold out positions, on the other hand, totaling 1,246,136 shares.

Short, Medium and Long Term Indicators

Assessing the average trade volume of a public company’s stock in the short, medium and long term is helpful to gain an understanding of trading activity and investor sentiment. Bioverativ Inc. (BIVV) has had a 20-day average volume of 1,079,005 shares, with an average of 100% of short term indicators pointed at Buy.

The stock’s 50-day average volume has been 1,259,342 shares, with an average of 50% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 1,139,360 shares with 33% of long-term indicators pointing to Buy.